Key result
Continuous wireless vital sign monitoring did not significantly reduce the median duration of severe vital sign deviations compared to standard care (60 vs 76 min/d; P=0.19).
Why the study?
Complications after major noncardiac surgery are often preceded by vital sign deviations undetected by current intermittent monitoring, and continuous wireless monitoring with real-time alerts may reduce abnormalities and complications.
Does continuous wireless vital sign monitoring with real-time alerts reduce the cumulative duration of severe vital sign deviations in adult patients undergoing major noncardiac surgery?
RCT (n=400)
Double-blind
Randomized
Does continuous wireless vital sign monitoring with real-time alerts reduce the cumulative duration of severe vital sign deviations in adult patients undergoing major noncardiac surgery?
Absolute Event Rate: 60% vs 76%
p-value: p=0.19
Continuous wireless vital sign monitoring with real-time alerts did not significantly reduce the cumulative duration of severe vital sign deviations compared to standard intermittent monitoring after major noncardiac surgery.
Does not support continuous wireless monitoring to reduce severe deviations after major surgery; challenges presumed benefits and leaves optimal implementation open.
BACKGROUND: Complications occur in a third of patients after major noncardiac surgery and are often preceded by vital sign deviations undetected by current vital sign monitoring practice, despite major advances in surgical and perioperative care. Continuous wireless vital sign monitoring with real-time alerts may allow for a reduction of vital sign abnormalities and complications. METHODS: Adult patients undergoing major noncardiac surgery were included and randomized to either standard of care (manual intermittent vital sign monitoring) vs standard of care plus continuous wireless vital sign monitoring with real-time vital sign alerts to staff smartphones at the general postoperative ward. The primary outcome was cumulative duration of severe vital sign deviations, including desaturation, tachy- and bradycardia, tachy- and bradypnea, hypo- and hypertension. Secondary outcomes included adverse events within 30 days. Patients and outcome assessors were blinded to the randomization. RESULTS: Four hundred patients were randomized, with 200 in the intervention and 200 in the control group, respectively. Median [interquartile range (IQR)] duration of severely deviating vital signs was 60 [25-136] vs 76 [28-192] min/d in the intervention versus control group, respectively ( P = .19). Duration of Sp o2 <88% had a mean reduction of 47 minutes per day (95% confidence interval [CI], 18-80, P = .02). Adverse events occurred in 42.5% vs 31.5% of patients within 30 days ( P = .02), and serious adverse events in 34.5% vs 29.5% ( P = .39). CONCLUSIONS: Continuous vital sign monitoring with real-time staff alerts did not significantly reduce cumulative severe vital sign deviations in this setup. Significant reductions in desaturations and adverse events were found, giving evidence to future studies in the use of continuous vital sign monitoring to improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Mølgaard et al. (2025) conducted an RCT in Major noncardiac surgery (n=400). Continuous wireless vital sign monitoring with real-time alerts vs. Standard of care (manual intermittent vital sign monitoring) was evaluated on Cumulative duration of severe vital sign deviations, including desaturation, tachy- and bradycardia, tachy- and bradypnea, hypo- and hypertension (p=0.19). Continuous wireless vital sign monitoring did not significantly reduce the median duration of severe vital sign deviations compared to standard care (60 vs 76 min/d; P=0.19).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: